Upgrade to SI Premium - Free Trial

ResMed (RMD)

198.02 +3.70 (1.90%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/30/26)

Latest Headlines

Form 4 RESMED INC For: Jun 01 Filed by: Rider Michael J June 3, 2026 3:45 PM - SEC Filing Form 144 RESMED INC Filed by: Sandercock Brett May 27, 2026 11:23 AM - SEC Filing Form SD RESMED INC May 26, 2026 4:41 PM - SEC Filing CLSA Reiterates Outperform (2) Rating on ResMed (RMD:AU) (RMD) May 25, 2026 5:49 AM - StreetInsider Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care May 19, 2026 9:00 AM - Globe NewsWire Needham Reiterates Hold Rating on ResMed (RMD) May 15, 2026 5:58 AM - StreetInsider Form 4 RESMED INC For: May 07 Filed by: Farrell Michael J. May 11, 2026 7:34 AM - SEC Filing Form 144 RESMED INC Filed by: Farrell Michael J. May 7, 2026 4:32 PM - SEC Filing ResMed (RMD:AU) (RMD) PT Lowered to AUD48 at Citi May 7, 2026 4:23 AM - StreetInsider Form 3 RESMED INC For: May 04 Filed by: Bloomer Aaron May 4, 2026 6:06 PM - SEC Filing Form 4 RESMED INC For: May 04 Filed by: Sandercock Brett May 4, 2026 5:55 PM - SEC Filing Form 10-Q RESMED INC For: Mar 31 May 1, 2026 9:42 AM - SEC Filing ResMed (RMD) PT Lowered to $225 at Baird May 1, 2026 8:22 AM - StreetInsider ResMed (RMD) PT Lowered to $235 at Stifel May 1, 2026 7:57 AM - StreetInsider ResMed (RMD) PT Lowered to $227 at Wells Fargo May 1, 2026 7:54 AM - StreetInsider ResMed (RMD) PT Raised to $321 at RBC Capital May 1, 2026 5:55 AM - StreetInsider ResMed (RMD) PT Lowered to $180 at Wolfe Research May 1, 2026 5:32 AM - StreetInsider ResMed (RMD) Tops Q3 EPS by 5c April 30, 2026 4:34 PM - StreetInsider Form 8-K RESMED INC For: Apr 24 April 30, 2026 4:15 PM - SEC Filing Form 8-K RESMED INC For: Apr 30 April 30, 2026 4:10 PM - SEC Filing ResMed CFO Brett Sandercock to retire, Aaron Bloomer named successor April 30, 2026 4:10 PM - StreetInsider Resmed Chief Financial Officer Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor  April 30, 2026 4:10 PM - Globe NewsWire Form SCHEDULE 13G RESMED INC Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC April 29, 2026 3:12 PM - SEC Filing Form SCHEDULE 13G RESMED INC Filed by: VANGUARD CAPITAL MANAGEMENT LLC April 29, 2026 10:44 AM - SEC Filing Macquarie: Energy was the only sector to post positive returns in Australia past month April 28, 2026 9:29 AM - StreetInsider ResMed (RMD:AU) (RMD) PT Lowered to AUD38.50 at CLSA April 28, 2026 5:53 AM - StreetInsider ResMed (RMD) PT Lowered to $286 at Morgan Stanley April 27, 2026 9:47 AM - StreetInsider ResMed (RMD) PT Lowered to $290 at KeyBanc April 27, 2026 8:32 AM - StreetInsider JPMorgan Resumes ResMed (RMD) at Overweight April 15, 2026 11:51 AM - StreetInsider JPMorgan Starts ResMed (RMD:AU) (RMD) at Overweight April 15, 2026 11:24 AM - StreetInsider ResMed (RMD) PT Lowered to $254 at Baird April 15, 2026 6:27 AM - StreetInsider ResMed (RMD) PT Lowered to $255 at Mizuho April 13, 2026 6:50 AM - StreetInsider Form 4 RESMED INC For: Apr 07 Filed by: Farrell Michael J. April 9, 2026 11:44 AM - SEC Filing Form 144 RESMED INC Filed by: Farrell Michael J. April 7, 2026 4:16 PM - SEC Filing Form 4 RESMED INC For: Apr 01 Filed by: Sandercock Brett April 3, 2026 7:29 AM - SEC Filing Form 4 RESMED INC For: Apr 01 Filed by: FARRELL PETER C April 2, 2026 1:52 PM - SEC Filing Form 144 RESMED INC Filed by: FARRELL PETER C April 1, 2026 5:30 PM - SEC Filing Form 144 RESMED INC Filed by: Sandercock Brett April 1, 2026 10:11 AM - SEC Filing Form SCHEDULE 13G/A RESMED INC Filed by: VANGUARD GROUP INC March 27, 2026 11:35 AM - SEC Filing Stifel Reiterates Hold Rating on ResMed (RMD), but Raises Estimates March 16, 2026 7:46 AM - StreetInsider Form 4 RESMED INC For: Mar 09 Filed by: Farrell Michael J. March 11, 2026 8:29 AM - SEC Filing ResMed (RMD) PT Lowered to $272 at Baird March 11, 2026 6:20 AM - StreetInsider Form 144 RESMED INC Filed by: Farrell Michael J. March 9, 2026 11:25 AM - SEC Filing Full Article List